Skip to main content
. 1999 Feb;43(2):381–384. doi: 10.1128/aac.43.2.381

TABLE 1.

Values of pharmacokinetic parameters of D-D4FC derived from monkeys given 33.3 mg/kg by i.v. or p.o. route

Route and model parametera Mean (n = 3) Minimum Maximum Fit to averaged data
i.v. route
t1/2α (h) 0.69 0.61 0.83 0.77
t1/2β (h) 3.57 3.46 3.75 3.26
 % AUC from α phase 53.5 46.3 57.8 53.2
 % AUC from β phase 46.5 42.2 53.7 46.8
k10 (h−1) 0.63 0.57 0.69 0.58
k12 (h−1) 0.27 0.17 0.34 0.20
k21 (h−1) 0.31 0.29 0.36 0.33
Vcentral (liter · kg−1) 0.68 0.58 0.79 0.70
VSS (liter · kg−1) 1.24 1.16 1.32 1.13
 CLsys (liter · kg−1 · h−1) 0.43 0.40 0.45 0.40
 AUC (μM · h) 345.5 327.4 363.9 363.5
 AUMC (μM · h−2) 1,014.1 917.1 1,075.7 1,017.3
 MRTi.v. (h) 2.93 2.80 3.12 2.80
r (n) 0.973 (10) 0.937 (10) 0.994 (10) 0.970
 CLR (liter · kg−1 · h−1) 0.31 0.27 0.35
p.o. route
ka (h−1) 0.64 0.50 0.86 0.26
 tlag (h) 0.88 0.00 1.83 0.00
F 0.41 0.24 0.49 0.41
r 0.94 0.90 0.99 0.90
Cmax (μM) 33.4 21.1 47.5
Tmax 2.67 1.00 4.00
 AUC (μM · h) 172.0 104.6 211.7
 AUMC (μM · h2) 1,029.8 669.7 1,242.1
 MRT p.o. (h) 6.06 5.56 6.40
 MAT (h) 3.13 2.68 3.42
a

The values of the model parameters were determined by simultaneously fitting the data for plasma following administration by the i.v. and oral routes to a two-compartment model. The model parameters included t1/2α and t1/2β, the respective disposition half-lives; k10 is the elimination rate constant from the central compartment; k12 and k21 are the disposition rate constants between the central and peripheral compartment; Vcentral is the distribution volume of the central compartment; VSS is the distribution volume once the compound has distributed throughout animal; CLR and CLsys are the renal and systemic clearances, respectively; Cmax is the observed maximum concentration in plasma, while Tmax is the time to Cmax. F is the fraction of the oral dose of compound absorbed. CLR was calculated for the i.v. dose as the ratio of compound recovered in the urine/AUC. AUC and AUMC values are the area under zero and first moment plasma concentration-versus-time curves, respectively; MRT is the mean residence time; r is the correlation coefficient, and n is the number of observation points. ka is the first-order oral absorption rate constant. The mean absorption time (MAT) was calculated as the difference between each animal’s own MRT after p.o. administration and the corresponding MRT after i.v. administration (4). CLR was calculated for the i.v. dose as the ratio of compound recovered in the urine to the corresponding AUC. CLR was not calculated for the oral dose, since renal excretion had not yet plateaued at the end of the urine collection interval.